Clinical trial
Activating Receptors and DAP12 Protein in Wegener's Granulomatosis
NCT01167491 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Activating Receptors and DAP12 Protein in Wegener's Granulomatosis
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- September 30, 2014
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wegener's granulomatosis